Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility

Oncogene volumeĀ 28,Ā pages 2839ā€“2848 (2009)Cite this article

Abstract

The Ste20-like kinase, SLK, is involved in the control of cell motility through its effects on actin reorganization and focal adhesion turnover. Here we investigated the role of SLK in chemotaxis downstream of the tyrosine kinase receptor, HER2/ErbB2/Neu, which is frequently overexpressed in human breast cancers. Our results show that SLK is required for the efficient cell migration of human and mouse mammary epithelial cell lines in the presence of the Neu activator, heregulin, as a chemoattractant. SLK activity is stimulated by heregulin treatment or by overexpression of activated Neu. Phosphorylation of tyrosine 1201 or tyrosines 1226/7 on Neu is a key event for SLK activation and cell migration, and cancer cell invasion mediated by these tyrosines is inhibited by kinase-inactive SLK. Signaling pathway inhibitors show that Neu-mediated SLK activation is dependent on MEK, PI3K, PLCĪ³ and Shc signaling. Furthermore, heregulin-stimulated SLK activity requires signals from the focal adhesion proteins, FAK and src. Finally, phospho-FAK analysis shows that SLK is required for Neu-dependent focal adhesion turnover. Together, these studies define an interaction between Neu and SLK signaling in the regulation of cancer cell motility.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Beerli RR, Wels W, Hynes NE . (1994). Intracellular expression of single chain antibodies reverts ErbB-2 transformation. J Biol Chem 269: 23931ā€“23936.

    CASĀ  PubMedĀ  Google ScholarĀ 

  • Benlimame N, He Q, Jie S, Xiao D, Xu YJ, Loignon M et al. (2005). FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. J Cell Biol 171: 505ā€“516.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Broussard JA, Webb DJ, Kaverina I . (2008). Asymmetric focal adhesion disassembly in motile cells. Curr Opin Cell Biol 20: 85ā€“90.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Burakov AV, Zhapparova ON, Kovalenko OV, Zinovkina LA, Potekhina ES, Shanina NA et al. (2008). Ste20-related protein kinase LOSK (SLK) controls microtubule radial array in interphase. Mol Biol Cell 19: 1952ā€“1961.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Cook TA, Nagasaki T, Gundersen GG . (1998). Rho guanosine triphosphatase mediates the selective stabilization of microtubules induced by lysophosphatidic acid. J Cell Biol 141: 175ā€“185.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Dankort D, Jeyabalan N, Jones N, Dumont DJ, Muller WJ . (2001a). Multiple ErbB-2/Neu phosphorylation sites mediate transformation through distinct effector proteins. J Biol Chem 276: 38921ā€“38928.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Dankort D, Maslikowski B, Warner N, Kanno N, Kim H, Wang Z et al. (2001b). Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol Cell Biol 21: 1540ā€“1551.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Dankort DL, Muller WJ . (1996). Transgenic models of breast cancer metastasis. Cancer Treat Res 83: 71ā€“88.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Dankort DL, Muller WJ . (2000). Signal transduction in mammary tumorigenesis: a transgenic perspective. Oncogene 19: 1038ā€“1044.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Dankort DL, Wang Z, Blackmore V, Moran MF, Muller WJ . (1997). Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation. Mol Cell Biol 17: 5410ā€“5425.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Ellinger-Ziegelbauer H, Karasuyama H, Yamada E, Tsujikawa K, Todokoro K, Nishida E . (2000). Ste20-like kinase (SLK), a regulatory kinase for polo-like kinase (Plk) during the G2/M transition in somatic cells. Genes Cells 5: 491ā€“498.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Frame MC . (2004). Newest findings on the oldest oncogene; how activated src does it. J Cell Sci 117: 989ā€“998.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ . (1992). Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578ā€“10582.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Hamadi A, Bouali M, Dontenwill M, Stoeckel H, Takeda K, Ronde P . (2005). Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397. J Cell Sci 118: 4415ā€“4425.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Hauck CR, Hsia DA, Schlaepfer DD . (2000). Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells. J Biol Chem 275: 41092ā€“41099.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Hauck CR, Sieg DJ, Hsia DA, Loftus JC, Gaarde WA, Monia BP et al. (2001). Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res 61: 7079ā€“7090.

    CASĀ  PubMedĀ  Google ScholarĀ 

  • Holbro T, Civenni G, Hynes NE . (2003). The ErbB receptors and their role in cancer progression. Exp Cell Res 284: 99ā€“110.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Holbro T, Hynes NE . (2004). ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 44: 195ā€“217.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Hynes NE, Lane HA . (2005). ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5: 341ā€“354.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Itoh S, Kameda Y, Yamada E, Tsujikawa K, Mimura T, Kohama Y . (1997). Molecular cloning and characterization of a novel putative STE20-like kinase in guinea pigs. Arch Biochem Biophys 340: 201ā€“207.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Khoury H, Dankort DL, Sadekova S, Naujokas MA, Muller WJ, Park M . (2001). Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor. Oncogene 20: 788ā€“799.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Kuramochi S, Moriguchi T, Kuida K, Endo J, Semba K, Nishida E et al. (1997). LOK is a novel mouse STE20-like protein kinase that is expressed predominantly in lymphocytes. J Biol Chem 272: 22679ā€“22684.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Lahlou H, Sanguin-Gendreau V, Zuo D, Cardiff RD, McLean GW, Frame MC et al. (2007). Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci USA 104: 20302ā€“20307.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Mansour EG, Ravdin PM, Dressler L . (1994). Prognostic factors in early breast carcinoma. Cancer 74: 381ā€“400.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Marone R, Hess D, Dankort D, Muller WJ, Hynes NE, Badache A . (2004). Memo mediates ErbB2-driven cell motility. Nat Cell Biol 6: 515ā€“522.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Mitra SK, Schlaepfer DD . (2006). Integrin-regulated FAKā€“Src signaling in normal and cancer cells. Curr Opin Cell Biol 18: 516ā€“523.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Northey JJ, Chmielecki J, Ngan E, Russo C, Annis MG, Muller WJ et al. (2008). Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion. Mol Cell Biol 28: 3162ā€“3176.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • O'Reilly PG, Wagner S, Franks DJ, Cailliau K, Browaeys E, Dissous C et al. (2005). The Ste20-like kinase SLK is required for cell cycle progression through G2. J Biol Chem 280: 42383ā€“42390.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Palazzo AF, Cook TA, Alberts AS, Gundersen GG . (2001). mDia mediates Rho-regulated formation and orientation of stable microtubules. Nat Cell Biol 3: 723ā€“729.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Palazzo AF, Gundersen GG . (2002). Microtubule-actin cross-talk at focal adhesions. Sci STKE 2002: PE31.

    PubMedĀ  Google ScholarĀ 

  • Pytowski B, Hicklin DJ, Kornhaber G, Dellaratta DV, Witte L . (1998). Identification and initial characterization of mSLK, a murine member of the STE20 family of kinases. Arch Biochem Biophys 359: 310ā€“319.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Sabourin LA, Rudnicki MA . (1999). Induction of apoptosis by SLK, a Ste20-related kinase. Oncogene 18: 7566ā€“7575.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Sabourin LA, Tamai K, Seale P, Wagner J, Rudnicki MA . (2000). Caspase 3 cleavage of the Ste20-related kinase SLK releases and activates an apoptosis-inducing kinase domain and an actin-disassembling region. Mol Cell Biol 20: 684ā€“696.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH et al. (2000). FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2: 249ā€“256.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Siegel PM, Dankort DL, Muller WJ . (2000). Oncogene mediated signal transduction in transgenic mouse models of human breast cancer. Adv Exp Med Biol 480: 185ā€“194.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Siesser PM, Meenderink LM, Ryzhova L, Michael KE, Dumbauld DW, Garcia AJ et al. (2008). A FAK/Src chimera with gain-of-function properties promotes formation of large peripheral adhesions associated with dynamic actin assembly. Cell Motil Cytoskeleton 65: 25ā€“39.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Wagner S, Flood TA, O'Reilly P, Hume K, Sabourin LA . (2002). Association of the Ste20-like kinase (SLK) with the microtubule. Role in Rac1-mediated regulation of actin dynamics during cell adhesion and spreading. J Biol Chem 277: 37685ā€“37692.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Wagner S, Storbeck CJ, Roovers K, Chaar ZY, Kolodziej P, McKay M et al. (2008). FAK/src-family dependent activation of the Ste20-like kinase SLK is required for microtubule-dependent focal adhesion turnover and cell migration. PLoS ONE 3: e1868.

    ArticleĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT et al. (2004). FAKā€“Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6: 154ā€“161.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Webb DJ, Parsons JT, Horwitz AF . (2002). Adhesion assembly, disassembly and turnover in migrating cellsā€”over and over and over again. Nat Cell Biol 4: E97ā€“E100.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Yamada E, Tsujikawa K, Itoh S, Kameda Y, Kohama Y, Yamamoto H . (2000). Molecular cloning and characterization of a novel human STE20-like kinase, hSLK. Biochim Biophys Acta 1495: 250ā€“262.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Zhang Y-H, Hume K, Cadonic R, Thompson C, Staines W, Hakim A et al. (2002). Expression of the Ste20-like kinase SLK during embryonic development and in the murine adult central nervous system. Brain Res Dev Brain Res 139: 205ā€“215.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

Download references

Acknowledgements

This work was supported by the Canadian Breast Cancer Foundation, the Canadian Institute for Health Research and a Premier's Research for Excellence Award. KR is supported by the Canadian Breast Cancer Foundation, SW is supported by OGSST and NSERC studentships and CJS is the recipient of a Canadian Heart and Stroke Foundation Fellowship. PMS is a research scientist of the National Cancer Institute of Canada and LAS is the recipient of a CIHR scholar award.

Author information

Authors and Affiliations

  1. Centre for Cancer Therapeutics, Ottawa Health Research Institute, Cancer Therapeutics, Ottawa, Ontario, Canada

    K Roovers,Ā C J Storbeck,Ā P O'ReillyĀ &Ā L A Sabourin

  2. Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada

    S Wagner,Ā V LoĀ &Ā L A Sabourin

  3. Department of Biochemistry, McGill University, Montreal, Quebec, Canada

    J J Northey,Ā W J MullerĀ &Ā P M Siegel

  4. Department of Medicine, McGill University, Montreal, Quebec, Canada

    J ChmieleckiĀ &Ā W J Muller

Authors
  1. K Roovers
    View author publications

    You can also search for this author in PubMedĀ Google Scholar

  2. S Wagner
    View author publications

    You can also search for this author in PubMedĀ Google Scholar

  3. C J Storbeck
    View author publications

    You can also search for this author in PubMedĀ Google Scholar

  4. P O'Reilly
    View author publications

    You can also search for this author in PubMedĀ Google Scholar

  5. V Lo
    View author publications

    You can also search for this author in PubMedĀ Google Scholar

  6. J J Northey
    View author publications

    You can also search for this author in PubMedĀ Google Scholar

  7. J Chmielecki
    View author publications

    You can also search for this author in PubMedĀ Google Scholar

  8. W J Muller
    View author publications

    You can also search for this author in PubMedĀ Google Scholar

  9. P M Siegel
    View author publications

    You can also search for this author in PubMedĀ Google Scholar

  10. L A Sabourin
    View author publications

    You can also search for this author in PubMedĀ Google Scholar

Corresponding author

Correspondence to L A Sabourin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roovers, K., Wagner, S., Storbeck, C. et al. The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility. Oncogene 28, 2839ā€“2848 (2009). https://doi.org/10.1038/onc.2009.146

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2009.146

Keywords

This article is cited by

Search

Advanced search

Quick links